Brief: Acurx Announces Results Of Its Pioneering Research With Ibezapolstat
24/09/2024 12:03
Sept 24 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX ANNOUNCES RESULTS OF ITS PIONEERING RESEARCH WITH
IBEZAPOLSTAT IN COLLABORATION WITH LEIDEN UNIVERSITY MEDICAL
CENTER AT THE PREMIER INTERNATIONAL C. DIFFICILE SYMPOSIUM
* ACURX PHARMACEUTICALS INC - FDA AGREES ON KEY ELEMENTS FOR
PHASE
3 TRIALS OF IBEZAPOLSTAT
Source text for Eikon: ID:nPn498Lzca
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln